Clinical Oncology/Epidemiology |
Clinical Oncology/Epidemiology
Filters
-
Article Type
- All (1819)
- Clinical Oncology/Epidemiology (1819)
-
Year
-
-
Clinical Oncology/Epidemiology |
Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer
- H Gabra
- , DA Cameron
- & RCF Leonard
-
Clinical Oncology/Epidemiology |
Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution
- DJ Kerr
- , AM Young
- & G Fountzilas
-
Clinical Oncology/Epidemiology |
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study
- DA Cameron
- , J Craig
- & W Miller
-
Clinical Oncology/Epidemiology |
Pain and other symptoms during the first year after radical and conservative surgery for breast cancer
- T Tasmuth
- , K von Smitten
- & E Kalso
-
Clinical Oncology/Epidemiology |
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity
- C Bokemeyer
- , LM Fels
- & H Lentzen
-
Clinical Oncology/Epidemiology |
High risk of lymphomas in children of Asian origin: ethnicity or confounding by socioeconomic status?
- C Varghese
- , JH Barrett
- & D Forman
-
Clinical Oncology/Epidemiology |
Trends in eye cancer mortality among adults in the USA and England and Wales
- AJE Foss
- & PJ Dolin
-
Clinical Oncology/Epidemiology |
Cancer mortality in French Polynesia between 1984 and 1992
- F de Vathaire
- & B Le Vu
-
Clinical Oncology/Epidemiology |
Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer
- J van den Berg
- , O Johannsson
- & A Borg
-
Clinical Oncology/Epidemiology |
Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins
- B Franzén
- , S Linder
- & G Auer
-
Clinical Oncology/Epidemiology |
High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer
- BG Taal
- , BMP Aleman
- & H Boot
-
Clinical Oncology/Epidemiology |
Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance
- L Kaklamanis
- , MI Koukourakis
- & AL Harris
-
Clinical Oncology/Epidemiology |
A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds
- PA Holland
- , J Walls
- & NJ Bundred
-
Clinical Oncology/Epidemiology |
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
- P Lissoni
- , F Paolorossi
- & M Chilelli
-
Clinical Oncology/Epidemiology |
Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists
- MH Cullen
- , LJ Billingham
- & CM Woodroffe
-
Clinical Oncology/Epidemiology |
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer
- AA Melcher
- , D Mort
- & TS Maughan
-
Clinical Oncology/Epidemiology |
Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer
- GJS Rustin
- , TG Quinnell
- & W Bollag
-
Clinical Oncology/Epidemiology |
Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic
- H Hjalgrim
- , M Melbye
- & A Ekbom
-
Clinical Oncology/Epidemiology |
Case-control study of risk factors for prostate cancer
- M Ilić
- , H Vlajinac
- & J Marinković
